Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
NAMS compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name
NAMS
NewAmsterdam Pharma Co N.V.
Change
Mkt cap
Revenue
Revenue
LLY
ELI Lilly & Co
Change
Mkt cap
Revenue
Revenue
vs
Compare
NAMS
NewAmsterdam Pharma Co N.V.
vs
LLY
ELI Lilly & Co
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
NAMS
NewAmsterdam Pharma Co N.V.
Change
20.17
▲
+3.12%
Mkt cap
$2.4B
Revenue
$4M
Q2 FY26
Revenue
$23M
FY25
LLY
ELI Lilly & Co
Change
1,420.18
▲
+0.65%
Regular session
Nov 3 '26
Mkt cap
$1.3T
Revenue
$24.4B
Q3 FY26
Revenue
$65.2B
FY25
vs
Compare
Regular session
Nov 3 '26
NAMS
NewAmsterdam Pharma Co N.V.
vs
LLY
ELI Lilly & Co
20.17
▲
+3.12%
Price
1,420.18
▲
+0.65%
$2.4B
Mkt cap
$1.3T
Q2 FY26
$4M
Revenue
$24.4B
Q3 FY26
FY25
$23M
Revenue
$65.2B
FY25
Change
Change
NAMS
20.17
▲
+3.12%
vs
LLY
1,420.18
▲
+0.65%
Regular session
Nov 3 '26
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
NAMS, solid
LLY, dashed
Supply-chain overlap
Revenue flow
NAMS: latest quarter is a loss; flow not drawable.
Method
›
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only NAMS
0
None
Shared
0
No disclosed counterparties: NAMS.
Only LLY
29
MCK
McKesson
customer
CAH
Cardinal Health
customer
VEEV
Veeva Systems
supplier
UTHR
United Therapeutics
customer
25 more · LLY chain
›
Role chip = supplier or customer
Source: SEC EDGAR